Ann: Imugene Dose Escalates in Phase I Clinical Trial of VAXINIA, page-101

how many times do we have to go over this....hervaxx is an immuno response vaccine....its not a cancer zapper.. the trial had patients on last legs and completely immuno compromised patients.

leslie knows it works and the best way to heal people will be in combination with existing approved drugs therefore getting it to market earlier.

make no mistake... it's all about getting the data validated and proving up the entire b-cell platform...and i anticipate a massive revenue stream to eventuate and cement this company's future...

then the real money maker will be on the form of OV therapies.

i respect peoples opinions equally but the dribble only occurs when people lose money... the stock market owes you nothing....and ...market makers control the book. I think everyone that needs to have shares is fully loaded way before the masses...all large shareholders are not selling from what i can see....

dyor and glta lth.

ps. i bought this stock so long ago that these milestones were just ideas. Imugene had met my expectations and then some...